netFormulary NHS
Ipswich and East Suffolk CCG
North East Essex CCG
East Suffolk and North East Essex NHS Foundation Trust
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Section
Notes:

Hospital only guidance

Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
08.01 Cytotoxic drugs (2,0)
Side-effects of cytotoxic drugs (0,1)
Drugs for cytotoxic-induced side-effects (4,3)
08.01.01 Alkylating drugs (11,0)
08.01.02 Anthracyclines and other cytotoxic antibiotics (10,2)
08.01.03 Antimetabolites (15,1)
08.01.04 Vinca alkaloids and etoposide (6,0)
08.01.05 Other antineoplastic drugs (20,11)
Amsacrine (1,0)
Arsenic trioxide (1,0)
Bevacizumab (4,0)
Bexarotene (0,1)
Bortezomib (1,0)
Brentuximab vedotin (1,0)
Cetuximab (1,0)
Crisantaspase (1,0)
Dacarbazine and Temozolomide (2,0)
Erlotinib (1,0)
Hydroxycarbamide (1,0)
Imatinab (0,0)
Ipilimumab (1,0)
Mitotane (0,1)
Panitumumab (0,0)
Pentostatin (1,0)
Platinum compounds (3,2)
Porfimer sodium and temoporfin (0,2)
Procarbazine (1,0)
Protein kinase inhibitors (17,0)
Taxanes (4,1)
Topoisomerase I inhibitors (2,0)
Trabectedin (1,0)
Trastuzumab (3,0)
Tretinoin (0,1)
Vismodegib (2,0)
08.02 Drugs affecting the immune response (1,0)
Immunosuppressant therapy (0,0)
08.02.01 Antiproliferative immunosuppressants (2,1)
08.02.02 Corticosteroids and other immunosuppressants (4,12)
08.02.03 Anti-lymphocyte monoclonal antibodies (5,0)
08.02.04 Other immunomodulating drugs (13,7)
Interferon Alfa (4,2)
Interferon beta (3,3)
Interferon gamma (0,0)
Aldesleukin (1,2)
BCG bladder instillation (0,0)
Canakinumab (0,0)
Glatiramer acetate (1,0)
Histamine (0,0)
Lenalidomide, pomalidomide, and thalidomide (0,0)
Mifamurtide (0,1)
Natalizumab (0,1)
Teriflunomide (0,0)
08.03 Sex hormones and hormone antagonists in malignant disease (0,0)
08.03.01 Oestrogens (1,1)
08.03.02 Progestogens (2,2)
08.03.03 Androgens (0,0)
08.03.04 Hormone antagonists (0,0)
08.03.04.01 Breast cancer (10,2)
08.03.04.02 Prostate cancer and gonadorelin analogues (0,1)
Gonadorelin analogues (6,0)
Anti-androgens (5,3)
Radiopharmaceuticals (0,0)
08.03.04.03 Somatostatin analogues (3,1)
netFormulary